Global Interventional Oncology Market 2017-2021
About Interventional Oncology
Interventional oncology procedures involve the diagnosis and treatment of cancer and cancer-related problems by using minimally invasive (MI) procedures performed under image guidance. Interventional oncology uses X-ray, ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to guide accessories and instruments, such as ablation electrodes, biopsy needles, guidewires, and intravascular catheters that allow the treatment of a tumor located in some part of the body. Interventional oncology treatments are regularly carried out by interventional radiologists with appropriate settings and facilities. Interventional oncology is used to treat primary or metastatic cancer, which includes liver cancer, lung cancer, kidney cancer, bone cancer, breast cancer, and prostate and pancreatic cancer.
Technavio’s analysts forecast the global interventional oncology market to grow at a CAGR of 11.17% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global interventional oncology market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of interventional oncology.
The market is divided into the following segments based on geography:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook